The cohesin-interacting protein, precocious dissociation of sisters 5A/sister chromatid cohesion protein 112, is up-regulated in human astrocytic tumors

International Journal of Molecular Medicine

Volumn 27, Issue 1, 2011, Pages 39-51

  Hagemann, Carsten ^a   Weigelin, Bettina ^a   Schommer, Stephan ^a   Schulze, Markus ^a   Al Jomah, Naif ^b   Anacker, Jelena ^a   Gerngras, Stefanie ^a   Kühnel, Siglinde ^a   Kessler, Almuth F ^a   Polat, Bülent ^a   Ernestus, Ralf Ingo ^a   Patel, Rajnikant ^b   Vince, Giles H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Astrocytoma; Cell cycle; Expression analysis; Glioblastoma multiforme; Glioma; Precocious dissociation of sisters 5A; Sister chromatid cohesion; Sister chromatid cohesion protein 112

Indexed keywords

MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN PRECOCIOUS DISSOCIATION OF SISTERS 5A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL SURVIVAL; CONTROLLED STUDY; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SISTER CHROMATID; TUMOR GROWTH; UPREGULATION;

ANEUPLOIDY; ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMATIDS; CHROMOSOMAL INSTABILITY; CHROMOSOMAL PROTEINS, NON-HISTONE; CLONING, MOLECULAR; GLIOBLASTOMA; HUMANS; MITOSIS; NUCLEAR PROTEINS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; TISSUE DISTRIBUTION;

EID: 78651084043     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2010.551     Document Type: Article

References (71)

1. Dey P: Aneuploidy and malignancy: an unsolved equation. J Clin Pathol 57: 1245-1249, 2004.
2. Rajagopalan H and Lengauer C: Aneuploidy and Cancer. Nature 432: 338-341, 2004.
3. Von Deinling A, Louis DN and Wiestler OD: Molecular pathways in the formation of gliomas. Glia 15: 328-338, 1995.
4. Cahill DP, Kinzler KW, Vogelstein B and Lengauer C: Genetic instability and darwinian selection in tumours. Trends Cell Biol 9: M57-M60, 1999.
5. Shapiro JR: Genetic alterations associated with adult diffuse astrocytic tumors. Am J Med Genet 115: 194-201, 2002.
6. Duesberg P, Li R, Fabarius A and Hehlmann R: The chromosomal basis of cancer. Cell Oncol 27: 293-318, 2005.
7. Gao CF, Furge K, Koeman J, Dykema K, Cutler ML, Werts A, Haak P and Vande Woude GF: Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc Natl Acad Sci USA 104: 8995-9000, 2007.
8. Lopes CS and Sunkel CE: The spindle checkpoint: From normal cell division to tumorigenesis. Arch Med Res 34: 155-165, 2003. (Pubitemid 36870704)
9. Bharadwaj R and Yu H: The spindle checkpoint, aneuploidy, and cancer. Oncogene 23: 2016-2027, 2004.
10. Tanaka K, Nishioka J, Kato K, Nakamura A, Mouri T, Miki C, Kusunoki M and Nobori T: Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. Jpn J Cancer Res 92: 952-958, 2001.
11. Shichiri M, Yoshinaga K, Hisatomi H, Sugihara K and Hirata Y: Genetic and epigenetic inactivation of mitotic checkpoint genes hBub1 and hBubR1 and their relationship to survival. Cancer Res 62: 13-17, 2002.
12. Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon DS, Wersto RP, Tully E, Wilsbach K and Gabrielson E: Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res 12: 405-410, 2006.
13. Babu JR, Jeganathan KB, Baker DJ, Wu X, Kang-Decker N and van Deursen JM: Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol 160: 341-353, 2003.
14. Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S, Mahmood R, Yang YM, Xu M and Rao CV: Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res 64: 440-445, 2004.
15. Sotillo R, Hernando E, Díaz-Rodríguez E, Teruya-Feldstein J, Cordón-Cardo, C, Lowe SW and Benezra R: Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11: 9-23, 2007.
16. Weaver BAA, Silk AD, Montagna C, Verdier-Pinard P and Cleveland DW: Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11: 25-36, 2007.
17. Matsuura S, Ito E, Tauchi H, Komatsu K, Ikeuchi T and Kajii T: Chromosomal instability syndrome of total premature chromatid separation with mosaic variegated aneuploidy is defective in mitotic-spindle checkpoint. Am J Hum Genet 67: 483-486, 2000.
18. Hanks S, Coleman K, Reid S, Plaja A, Firth H, FitzPatrick D, Kidd A, Méhes K, Nash R, Robin N, Shannon N, Tolmie J, Swansbury J, Irrthum A, Douglas J and Rahman N: Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36: 1159-1161, 2004.
19. Hanks S, Coleman K, Summersgill B, Messahel B, Williamson D, Pritchard-Jones, K, Strefford J, Swansbury J, Plaja A, Shipley J and Rahman N: Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome. Cancer Lett 239: 234-238, 2006. (Pubitemid 43977858)
20. Matsuura S, Matsumoto Y, Morishima K, Izumi H, Matsumoto H, Ito E, Tsutsui K, Kobayashi J, Tauchi H, Kajiwara Y, Hama S, Kuriso K, Tahara H, Oshimura M, Komatsu K, Ikeuchi T and Kajii T: Monoallelic BUB1B mutations and defective mitotic0spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome. Am J Med Genet 140: 358-367, 2006.
21. Kajii T, Ikeuchi T, Yang ZQ, Makamura Y, Tsuji Y, Yokomori K, Kawamura M, Fukuda S, Horita S and Asamoto A: Cancer-prone syndrome of mosaic variegated aneuploidy and total premature chromatid separation: Report of five infants. Am J Med Genet 104: 57-64, 2001.
22. Plaja A, Vendrell T, Smeets D, Sarret E, Gili T, Català V, Mediano C and Scheres JM: Variegated aneuploidy related to premature centromere division (PCD) is expressed in vivo and is a cancer-prone disease. Am J Med Genet 98: 216-223, 2001.
23. Hartman T, Stead K, Koshland D and Guacci V: Pds5p is an essential chromosomal protein required for both sister chromatid cohesion and condensation in Saccharomyces cerevisiae. J Cell Biol 151: 613-626, 2000.
24. Sumara I, Vorlaufer E, Gieffers C, Peters BH and Peters JM: Characterization of vertebrate cohesin complexes and their regulation in prophase. J Cell Biol 151: 749-761, 2000.
25. Kumar D, Sakabe I, Patel S, Zhang Y, Ahmad I, Gehan EA, Whiteside TL and Kasid U: SCC-112, a novel cell cycle-regulated molecule, exhibits reduced expression in human renal carcinomas. Gene 328: 187-196, 2004.
26. Zheng MZ, Zheng LM and Zeng YX: SCC-112 gene is involved in tumor progression and promotes the cell proliferation in G2/M phase. J Cancer Res Clin Oncol 134: 453-462, 2008.
27. Panizza S, Tanaka T, Hochwagen, A, Eisenhaber F and Nasmyth K: Pds5 cooperates with cohesin in maintaining sister chromatid cohesion. Curr Biol 10: 1557-1564, 2000.
28. Wang F, Yoder J, Antoshechkin I and Han M: Caenorhabditis elegans EVL-14/PDS-5 and SCC-3 are essential for sister chromatid cohesion in meiosis and mitosis. Mol Cell Biol 23: 7698-7707, 2003.
29. Losada A, Yokochi T and Hirano T: Functional contribution of Pds5 to cohesin-mediated cohesion in human cells and Xenopus egg extracts. J Cell Sci 118: 2133-2141, 2005.
30. Guacci V: Sister chromatid cohesion: the cohesin cleavage model does not ring true. Genes Cells 12: 693-708, 2007.
31. Yu H: Regulation of APC-Cdc20 by the spindle checkpoint. Curr Opin Cell Biol 14: 706-714, 2002.
32. Nasmyth K and Haering CH: The structure and function of SMC and kleisin complexes. Annu Rev Biochem 74: 595-648, 2005.
33. Uhlmann F: What is your assay for sister-chromatid cohesion? EMBO J 26: 4609-4618, 2007.
34. Tanaka K, Hao Z, Kai M and Okayama H: Establishment and maintenance of sister chromatid cohesion in fission yeast by a unique mechanism. EMBO J 20: 5779-5790, 2001. (Pubitemid 33010053)
35. Stead K, Aguilar C, Hartman T, Drexel M, Meluh P and Guacci V: Pds5p regulates the maintenance of sister chromatid cohesion and is sumoylated to promote the dissolution of cohesion. J Cell Biol 163: 729-741, 2003.
36. Zhang B, Chang J, Fu M, Huang J, Kashyap R, Salavaggione E, Jain S, Kulkarni S, Deardorff MA, Uziella ML, Dorsett D, Beebe DC, Jay PY, Heuckeroth RO, Krantz I and Milbrandt J: Dosage effects of cohesin regulatory factor PDS5 on mammalian development: Implications for cohesinopathies. PloS One 4: e5232, 2009.
37. Kadyk LC and Hartwell LH: Sister chromatids are preferred over homologs as substrates for recombinational repair in Saccharomyces cerevisiae. Genetics 132: 387-402, 1992.
38. Jin H, Guacci V and Yu H-G: Pds5 is required for homologue pairing and inhibits synapsis of sister chromatids during yeast miosis. J Cell Biol 186: 713-725, 2008.
39. Moreau PJF, Zickler D and Leblon G: One class of mutants with disturbed centromere cleavage and chromosome pairing in Sordaria macrospora. Mol Gen Genet 198: 189-197, 1985.
40. Denison SH, Kafer E and May GS: Mutation in the bimD gene of Aspergillus nidulans confers a conditional mitotic block and sensitivity to DNA damaging agents. Genetics 134: 1085-1096, 1993.
41. Wang SW, Read RL and Norbury CJ: Fission yeast Pds5 is required for accurate chromosome segregation and for survival after DNA damage or metaphase arrest. J Cell Sci 115: 587-598, 2002.
42. Terret M-E, Sherwood R, Rahman S, Qin J and Jallepalli PV: Cohesin acetylation speeds the replication fork. Nature 462: 231-235, 2009.
43. Heller RC and Marians KJ: Replisome assembly and the direct restart of stalled replication forks. Nat Rev Mol Cell Biol 7: 932-943, 2006.
44. Cianculli AM, Morace E, Coletta AM, Occhipinti E, Gandolfo GM, Leorardo G and Carapella CM: Investigation of genetic alterations associated with development and adverse outcome in patients with astrocytic tumor. J Neurooncol 48: 95-101, 2000.
45. Loeper S, Romeike BFM, Heckmann N, Jung V, Henn W, Feiden W, Zhang KD and Urbschat S: Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas. Cytogenet Cell Genet 94: 1-8, 2001.
46. Reifenberger G and Collins VP: Pathology and molecular genetics of astrocytic gliomas. J Mol Med 82: 656-670, 2004.
47. Cavenee WK, Furnari FB, Nagane M, Huang H-JS, Newcomb EW, Bigner DD, Weller M, Berens ME, Plate KH, Israel MA, Noble MD and Kleihues P: Diffusely infiltrating astrocytomas. In: Pathology and Genetics of Tumors of the Nervous System. WHO Classification of Tumors. Kleihues P and Cavenee WK (eds). IARC Press, Lyon, pp10-21, 2000.
48. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
49. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC and Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-225, 2002.
50. Stojic J, Hagemann C, Haas S, Herbold C, Kühnel S, Gerngras S, Roggendorf W, Roosen K and Vince GH: Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res 60: 40-49, 2008.
51. Akslen LA, Andersen KJ and Bjerkvig R: Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 8: 797-803, 1988.
52. Hagemann C, Meyer C, Stojic J, Eicker S, Gerngras S, Kühnel S, Roosen K and Vince GH: High efficiency transfection of glioma cell lines and primary cells for overexpression and RNAi experiments. J Neurosci Methods 156: 194-202, 2006.
53. Hagemann C, Gloger J, Anacker J, Said HM, Gerngras S, Kühnel S, Meyer C, Rapp UR, Kämmerer U, Vordermark D, Flentje M, Roosen K and Vince GH: RAF expression in human astrocytic tumors. Int J Mol Med 23: 17-31, 2009.
54. Hagemann C, Anacker J, Gerngras S, Kühnel S, Said HM, Patel R, Kämmerer U, Vordermark D, Roosen K and Vince GH: Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle like, microcephaly associated) in human malignant gliomas. Oncol Rep 20: 301-308, 2008.
55. Kitajima TS, Sakuno T, Ishiguro K, Iemura S, Natsume T, Kawashima SA and Watanabe Y: Shugoshin collaborates with protein phosphatase 2A to protect cohesin. Nature 441: 46-52, 2003.
56. Ren Q, Yang H, Gao B and Zhang Z: Global transcriptional analysis of yeast cell death induced by mutation of sister chromatid cohesin. Comp Funct Genomics 634283, 2008.
57. Ibdaih A, Omuro A, Ducray F and Hoang-Xuan K: Molecular genetic markers as predictors of response to chemotherapy in gliomas. Curr Opin Oncol 19: 606-611, 2007.
58. Gerson SL: MGMT: Its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 4: 296-307, 2004.
59. Newlands ES, Stevens MFG, Wedge SR, Wheelhouse RT and Brock C: Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 23: 35-61, 1997.
60. Ren Q, Yang H, Rosinski M, Conrad MN, Dresser ME, Guacci V and Zhang Z: Mutation of the cohesin related gene PDS5 causes cell death with predominant apoptotic features in Saccharomyces cerevisiae during early mitosis. Mutat Res 570: 163-173, 2005.
61. Geck P, Szelei J, Jimenez J, Sonnenschein C and Soto AM: Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus. J Steroid Biochem Mol Biol 68: 41-50, 1999.
62. Maffini M, Denes V, Sonnenschein C, Soto A and Geck P: APRIN is a unique Pds5 paralog with features of a chromatin regulator in homonal differentiation. J Steroid Biochem Mol Biol 108: 32-43, 2008.
63. Zhang Y, Huang X, Qi J, Yan C, Xu X, Han Y and Wang M: Correlation of genomic and expression alterations of AS3 with esophageal squamous cell carcinoma. J Genet Genomics 35: 267-271, 2008.
64. Denes V, Pilichowska M, Makarovskiy A, Carpinito G and Geck P: Loss of a cohesin-linked suppressor APRIN (Pds5b) disrupts stem cell programs in embryonal carcinoma: an emerging cohesin role in tumor suppression. Oncogene 29: 3446-3452, 2010.
65. Shintomi K and Hirano T: Releasing cohesin from chromosome arms in early mitosis: opposing actions of Wap1-Pds5 and Sgo1. Genes Dev 23: 2224-2236, 2009.
66. Sutani T, Kawaguchi T, Kanno R, Itoh T and Shirahige K: Budding yeast Wpl1 (Rad61)-Pds5 complex counteracts sister chromatid cohesion-establishing reaction. Curr Biol 19: 492-497, 2009.
67. Dorsett D: Cohesin, gene expression and development: Lessons from Drosophila. Chromosome Res 17: 185-200, 2009.
68. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE and Fuller GN: Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25: 55-57, 2000.
69. Ding H, Roncari L, Shannon P, Wu X, Lau N, Karaskova J, Gutmann DH, Squire JA, Nagy A and Guha A: Astrocyte specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res 61: 3826-3836, 2001.
70. Edwards LA, Verreault M, Thiessen B, Dragowska, WH, Hu Y, Yeung JHF, Dedhar S and Bally MB: Combined inhibition of the phosphatidyl 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells. Mol Cancer Ther 5: 645-654, 2006.
71. Sathornsumetee S, Hjelmeland AB, Keir ST, McLendon RE, Batt D, Ramsey T, Yusuff N, Rasheed BK, Kieran MW, Laforme A, Bigner DD, Friedman HS and Rich JN: AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma. Cancer Res 66: 8722-8730, 2006.